Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2023 ∙ Udomkarnjananun, S. Gatechompol, S. Leelahavanichkul, A. Kerr, S. J.

Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Shahsavarinia, K. Faridaalaee, G. Soleimanpour, H. Sadeghi-Ghyassi, F. Atashgahi, S. Milanchian, N. Abolhasanpour, N. Salehi-Pourmehr, H.

Cerebral Venous Thrombosis (CVT) Following COVID-19 Vaccination: an Umbrella Review of Systematic Reviews

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Song, T. J. Shin, J. I. Yon, D. K. Lee, S. W. Hwang, S. Y. Hwang, J. Park, S. H. Lee, S. B. Lee, M. H. Kim, M. S. Koyanagi, A. Tizaoui, K. Kim, J. H. Smith, L.

Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Faghihi, H. Mottaghi-Dastjerdi, N. Sharifzadeh, M. Rahimi Kakavandi, N.

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Cinconze, E. Rosillon, D. Rappuoli, R. Vadivelu, K. Bekkat-Berkani, R. Abbing-Karahagopian, V.

Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Meningococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Rahmadhan, M. A. W. P. Handayani, P. W.

Challenges of vaccination information system implementation: A systematic literature review

  • All age groups
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Albakri, K. Abdelwahab, O. A. Gabra, M. D. Nafady, M. H. Alabdallat, Y. J. Soliman, A. Cadri, S. Hanaqtah, B. Albazee, E.

Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wiley, K. Christou-Ergos, M. Degeling, C. McDougall, R. Robinson, P. Attwell, K. Helps, C. Drislane, S. Carter, S. M.

Childhood vaccine refusal and what to do about it: a systematic review of the ethical literature

  • Parents/caregivers
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Rosca, E. C. Bilavu, R. Cornea, A. Simu, M.

Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Alijanzadeh, D. Soltani, A. Afra, F. Salmanpour, F. Loghman, A. H. Samieefar, N. Rezaei, N.

Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...